David H. Reifsnyder

1.7k total citations · 1 hit paper
13 papers, 1.4k citations indexed

About

David H. Reifsnyder is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Spectroscopy. According to data from OpenAlex, David H. Reifsnyder has authored 13 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Spectroscopy. Recurrent topics in David H. Reifsnyder's work include Growth Hormone and Insulin-like Growth Factors (5 papers), Analytical Chemistry and Chromatography (3 papers) and Phosphodiesterase function and regulation (3 papers). David H. Reifsnyder is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (5 papers), Analytical Chemistry and Chromatography (3 papers) and Phosphodiesterase function and regulation (3 papers). David H. Reifsnyder collaborates with scholars based in United States. David H. Reifsnyder's co-authors include Joseph A. Beavo, Byron Gallis, Scott A. Harrison, G G Cadd, Stuart E. Builder, Philip Lester, Kenneth M. Lerea, Colin H. Macphee, Thomas A. Moore and John R. Ogez and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and Biochemical Journal.

In The Last Decade

David H. Reifsnyder

13 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors

1990 762 citations Joseph A. Beavo, David H. Reifsnyder Trends in Pharmacological Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David H. Reifsnyder United States	12	984	356	211	173	168	13	1.4k
Paul M. Epstein United States	26	1.5k 1.6×	250 0.7×	187 0.9×	320 1.8×	229 1.4×	64	2.0k
Sönke Behrends Germany	23	902 0.9×	936 2.6×	314 1.5×	93 0.5×	230 1.4×	65	1.8k
Kimiko Ishiguro United States	25	822 0.8×	177 0.5×	102 0.5×	81 0.5×	77 0.5×	71	1.5k
Steven J. Feinmark United States	21	675 0.7×	230 0.6×	365 1.7×	181 1.0×	205 1.2×	45	1.4k
Akihiko Kuniyasu Japan	25	929 0.9×	290 0.8×	208 1.0×	53 0.3×	180 1.1×	61	1.8k
Annie‐France Prigent France	21	768 0.8×	241 0.7×	67 0.3×	133 0.8×	97 0.6×	54	1.3k
J.M. Boeynaems Belgium	26	882 0.9×	434 1.2×	197 0.9×	130 0.8×	231 1.4×	55	2.1k
Roger J. Hill United States	20	720 0.7×	197 0.6×	227 1.1×	27 0.2×	219 1.3×	30	1.2k
Brian W. Kimes United States	8	1.1k 1.2×	151 0.4×	249 1.2×	76 0.4×	335 2.0×	10	1.7k
H Hidaka Japan	21	893 0.9×	187 0.5×	130 0.6×	51 0.3×	288 1.7×	44	1.3k

Countries citing papers authored by David H. Reifsnyder

Since Specialization

Citations

This map shows the geographic impact of David H. Reifsnyder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Reifsnyder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Reifsnyder more than expected).

Fields of papers citing papers by David H. Reifsnyder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Reifsnyder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Reifsnyder. The network helps show where David H. Reifsnyder may publish in the future.

Co-authorship network of co-authors of David H. Reifsnyder

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Reifsnyder. A scholar is included among the top collaborators of David H. Reifsnyder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Reifsnyder. David H. Reifsnyder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Fahrner, Robert, Philip Lester, Gregory S. Blank, & David H. Reifsnyder. (1999). Non-flammable preparative reversed-phase liquid chromatography of recombinant human insulin-like growth factor-I. Journal of Chromatography A. 830(1). 127–134. 11 indexed citations

Fahrner, Robert, Philip Lester, Gregory S. Blank, & David H. Reifsnyder. (1998). Real-time control of purified product collection during chromatography of recombinant human insulin-like growth factor-I using an on-line assay. Journal of Chromatography A. 827(1). 37–43. 23 indexed citations

Mortensen, Deborah L., Wesley Won, Jason J. Siu, et al.. (1997). Insulin-Like Growth Factor Binding Protein-1 Induces Insulin Release in the Rat. Endocrinology. 138(5). 2073–2080. 22 indexed citations

Reifsnyder, David H., et al.. (1996). Purification of insulin-like growth factor-I and related proteins using underivatized silica. Journal of Chromatography A. 753(1). 73–80. 7 indexed citations

Olson, Charles V., David H. Reifsnyder, Eleanor Canova‐Davis, Victor T. Ling, & Stuart E. Builder. (1994). Preparative isolation of recombinant human insulin-like growth factor 1 by reversed-phase high-performance liquid chromatography. Journal of Chromatography A. 675(1-2). 101–112. 20 indexed citations

Hart, Roger A., Philip Lester, David H. Reifsnyder, John R. Ogez, & Stuart E. Builder. (1994). Large Scale, In Situ Isolation of Periplasmic IGF–I from E. coli. Bio/Technology. 12(11). 1113–1117. 85 indexed citations

Nashabeh, Wassim, Daniel Kirby, František Foret, et al.. (1994). Incorporation of hydrophobic selectivity in capillary electrophoresis: analysis of recombinant insulin-like growth factor I variants. Analytical Chemistry. 66(13). 2148–2154. 59 indexed citations

CHAN, S, et al.. (1993). Immunochemical characterization of the distinct monocyte cyclic AMP-phosphodiesterase from patients with atopic dermatitis. Journal of Allergy and Clinical Immunology. 91(6). 1179–1188. 63 indexed citations

Canova‐Davis, Eleanor, et al.. (1992). Chemical heterogeneity as a result of hydroxylamine cleavage of a fusion protein of human insulin-like growth factor I. Biochemical Journal. 285(1). 207–213. 22 indexed citations

10.

Beavo, Joseph A. & David H. Reifsnyder. (1990). Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends in Pharmacological Sciences. 11(4). 150–155. 762 indexed citations breakdown →

11.

Macphee, Colin H., David H. Reifsnyder, Thomas A. Moore, Kenneth M. Lerea, & Joseph A. Beavo. (1988). Phosphorylation results in activation of a cAMP phosphodiesterase in human platelets.. Journal of Biological Chemistry. 263(21). 10353–10358. 118 indexed citations

12.

Harrison, Scott A., David H. Reifsnyder, Byron Gallis, G G Cadd, & Joseph A. Beavo. (1986). Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.. Molecular Pharmacology. 29(5). 506–514. 205 indexed citations

13.

Reifsnyder, David H., Clyde T. Young, & Evan E. Jones. (1984). The Use of Low Protein Liquid Diets to Determine the Methionine Requirement and the Efficacy of Methionine Hydroxy Analogue for the Three-Week-Old Pig. Journal of Nutrition. 114(9). 1705–1715. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact